Oral gavage subchronic neurotoxicity and inhalation subchronic immunotoxicity studies of ethylbenzene in the rat

NeuroToxicology

Volumn 31, Issue 3, 2010, Pages 247-258

  Li, Abby A ^a   Maurissen, Jacques P J ^b   Barnett, John F ^c   Foss, John ^c   Freshwater, Les ^d   Garman, Robert H ^e   Peachee, Vanessa L ^f   Hong, Sandra J ^a   Stump, Donald G ^g   Bus, James S ^b  

^a EXPONENT INC   (United States)

^b DOW CHEMICAL COMPANY   (United States)

^c CHARLES RIVER LABORATORIES   (United States)

^d BioSTAT Consultants   (United States)

^e Veterinary Pathology Inc   (United States)

^f ImmunoTox Inc   (United States)

^g WIL RESEARCH LABORATORIES   (United States)

Author keywords

Ethylbenzene; Immunotoxicity; Inhalation; Neurotoxicity; Oral; Rat

Indexed keywords

ETHYLBENZENE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BODY WEIGHT; CHRONIC TOXICITY; CONCENTRATION PROCESS; CONTROLLED STUDY; EXPERIMENTAL RAT; FEEDING; FEMALE; FOOD INTAKE; IMMUNOTOXICITY; KIDNEY MASS; LIVER WEIGHT; MALE; MOTOR ACTIVITY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SHEEP ERYTHROCYTE; TOXICITY TESTING;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; BENZENE DERIVATIVES; BODY WEIGHT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEMALE; KIDNEY DISEASES; LIVER DISEASES; MALE; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; NEUROTOXICITY SYNDROMES; NEUROTOXINS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; OPHTHALMOLOGY; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS;

ANIMALIA; OVIS ARIES; RATTUS;

EID: 77952670411     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.02.001     Document Type: Review

References (46)

1. ACGIH (American Conference of Governmental Industrial Hygienists). Documentation of the threshold limit values and biological exposure indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 1986. p. 244.
2. Ashley D.L., Bonin M.A., Cardinali F.L., McCraw J.M., Wooten J.V. Blood levels of volatile organic compounds in a nonoccupationally exposed US population and in groups with suspected exposure. Clin Chem 1994, 40:1401-1404.
3. ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological profile for ethylbenzene; 2007.
4. Churchill J.E., Ashley D.L., Kaye W.E. Recent chemical exposures and blood volatile organic compounds in a large population-based sample. Arch Environ Health 2001, 56:157-166.
5. Cragg S., Clarke E.A., Daly I.W., Miller R.R., Terrill J.B., Ouellette R.E. Subchronic inhalation toxicity of ethylbenzene in mice, rats, and rabbits. Fund Appl Toxicol 1989, 13:399-408.
6. Dunn O.J. Multiple comparisons using rank sums. Technometrics 1964, 6(3):241-252.
7. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 1955, 50:1096-1121.
8. Engström K., Riihimäki V., Laine A. Urinary disposition of ethylbenzene and m-xylene in man following separate and combined exposure. Int Arch Occup Environ Health 1984, 54:355-363.
9. Engström K., Elovaara E., Aitio A. Metabolism of ethylbenzene in the rat during long-term intermittent inhalation exposure. Xenobiotica 1985, 15:281-286.
10. Faber W.D., Roberts L.S.G., Stump D.G., Tardif R., Krishnan K., Tort M., et al. Two generation reproduction study of ethylbenzene by inhalation in Crl-CD rats. Birth Defects Res (Part B) 2006, 77:10-21.
11. Faber W.D., Roberts L.S.G., Stump D.G., Beck M., Kirkpatrick D., Regan K.S., et al. An inhalation developmental neurotoxicity study of ethylbenzene in Crl-CD rats. Birth Defects Res (Part B) 2007, 80:34-48.
12. Gross A.J., Clark V.A. Gehan-Wilcoxon test. Survival distribution: reliability applications in biomedical sciences 1975, 120-123. John Wiley and Sons, New York, NY. A.J. Gross, V.A. Clark (Eds.).
13. Haggerty G.C. Development of Tier I neurobehavioral testing capabilities for incorporation into pivotal rodent safety assessment studies. J Am Colloid Toxicol 1989, 8(1):53-69.
14. Imaoka S., Funae Y. Induction of cytochrome P450 isozymes in rat liver by methyl n-alkyl ketones and n-alkylbenzenes. Effects of hydrophobicity of inducers on inducibility of cytochrome P450. Biochem Pharmacol 1991, 42:S143-S150.
15. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmcology (Berlin) 1968, 13:222-257.
16. Jerne N.K., Nordin A.A., Henry C. The agar plaque technique for recognizing antibody-producing cell. Cell bound antibodies 1963, Wistar Institute Press, Philadelphia, PA. B. Amos, H. Koprowski (Eds.).
17. Krishnan K. Estimation of oral doses for use in a preliminary reproduction study of ethylbenzene in rat. Updated analysis provided by G. Charest. Arlington, VA: Unpublished report sponsored by the Ethylbenzene Panel, American Chemistry Council; 2002.
18. ® for linear models 2002, SAS Institute Inc., Cary, NC. 4th ed.
19. Mantel N. Chi-square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963, 58:690-700.
20. Mellert W., Deckardt K., Kaufmann W., van Ravenzwaay B. Ethylbenzene: 4- and 13-week rat oral toxicity. Arch Toxicol 2007, 81:361-370.
21. Molnar J., Paksy K.A., Naray M. Changes in the rat's motor behaviour during 4-h inhalation exposure to prenarcotic concentrations of benzene and its derivatives. Acta Physiol Hung 1986, 67:349-354.
22. Moser V.C. Screening approaches to neurotoxicity: a functional observational battery. J Am Colloid Toxicol 1989, 8(1):85-93.
23. Needham L.L., Hill R.H., Ashley D.L., Pirkle J.L., Sampson E.J. The priority toxicant reference range study: interim report. Environ Health Perspect 1995, 103(Suppl. 3):89-94.
24. National Research Council. Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources, commission on life Sciences. Washington, DC: National Academy Press; 1996.
25. NTP (National Toxicology Program). Toxicity studies of ethylbenzene (CAS No. 100-41-4) in F344/N rats and B6C3F1 mice (inhalation studies). NTP Tox. 10. NIH Publication No. 92-3129. PB93-149722. Research Triangle Park, NC: National Toxicology Program, U.S. Dept. of Health and Human Services; 1992.
26. NTP (National Toxicology Program). Tenth report on carcinogens. Research Triangle Park, NC: National Toxicology Program, U.S. Dept. of Health and Human Services; 2002.
27. O'Donoghue J.L. Screening for neurotoxicity using a neurologically based examination and neuropathology. J Am Colloid Toxicol 1989, 8(1):97-115.
28. OECD (Organisation for Economic Co-operation and Development). SIDS initial assessment report for 14th SIAM: ethylbenzene, CAS No. 100-41-4. Sponsor Country USA and Germany; 2002 [Date of circulation 1 February 2002, ]. http://www.chem.unep.ch/irptc/sids/OECDSIDS/sidspub.html.
29. Pirie W. Jonckheere tests for ordered alternatives. Encyclopedia of statistical sciences 1983, vol. 4:315-318. John Wiley and Sons, Inc., New York, NY.
30. Saghir S.A., Rick D.L., Bartels M.J., Bus J.S. In vitro metabolism of ethylbenzene by rat, mouse and human liver and lung microsomes. Toxicologist 2006, 90:141.
31. Saillenfait A.M., Gallissot F., Morel G., Bonnet P. Developmental toxicities of ethylbenzene, ortho-, meta-, para-xylene and technical xylene in rats following inhalation exposure. Food Chem Toxicol 2003, 41:415-429.
32. SAS Institute, Inc. SAS/STAT® user's guide, version 8. Cary, NC: SAS Institute, Inc.; 1999.
33. Sequeira D.J., Eyer C.S., Cawley G.F., Nick T.G., Backes W.L. Ethylbenzene mediated induction of cytochrome P450 isozymes in male and female rats. Biochem Pharmacol 1992, 44:1171-1182.
34. Sexton K., Adgate J.L., Church T.R., Ashley D.L., Needham L.L., Ramachandran G., et al. Children's exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ Health Perspect 2005, 113:342-349.
35. Siegel S. The Fisher's exact probability test. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill Co.; 1956. p. 96-104.
36. Snedecor G.W., Cochran W.G. Analysis of variance. Statistical methods 1967, Iowa State University Press, Ames, p. 258-98. 6th ed.
37. Sokal R.R., Rohlf F.J. Biometry 1969, W.H. Freeman and Co., San Francisco.
38. ® system 2000, SAS Institute Inc., Cary, NC. 2nd ed.
39. Tardif R., Charest-Tardif G., Brodeur J., Krishnan K. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol Appl Pharm 1997, 144:120-134.
40. Tegeris J.S., Balster R.L. A comparison of the acute behavioral effects of alkylbenzenes using a functional observational battery in mice. Fund Appl 1994, 22(2):240-250.
41. Tukey J.W., Ciminera J.L., Heyse J.F. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 1985, 41:295-301.
42. USEPA (United States Environmental Protection Agency). Health effects test guidelines OPPTS 870.6200 neurotoxicity screening battery; 1998a.
43. USEPA (United States Environmental Protection Agency). Health effects test guidelines OPPTS 870.7800 immunotoxicity; 1998b.
44. Yant W.P., Schrenk H.H., Waite C.P., Patty F.A. Acute response of guinea pigs to vapors of some new commercial organic compounds. II. Ethylbenzene. Pub Health Rep 1930, 45:1241-1250.
45. Yuan W., Sequeira D.J., Cawley G.F., Eyer C.S., Backes W.L. Time course for the modulation of hepatic cytochrome P450 after administration of ethylbenzene and its correlation with toluene metabolism. Arch Biochem Biophys 1997, 339:55-63.
46. Yuan W., Serron S.C., Cawley G.F., Eyer C.S., Backes W.L. Ethylbenzene modulates the expression of different cytochrome P-450 isozymes by discrete multistep processes. Biochim Biophys Acta 1997, 1334:361-372.